Compare Mesoblast Limited (MESO) vs Sea Limited (SE) Price & Performance

Mesoblast LimitedTrade

Sea LimitedTrade

Price performance (Past 24H)

Key statistics

Mesoblast Limited vs Sea Limited — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Sea Limited trades at $129.92 (market cap $80.55B). The key difference: Sea Limited is far larger — about 36.4× Mesoblast Limited's market cap. Which is the better fit depends on your goals.

	MESO	SE
Market Cap	$2.21B	$80.55B
Sector	Technology	Media
52-Week High	$20.96	$196.50
52-Week Low	$12.88	$78.16
Enterprise Value	$2.21B	$75.58B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MESO

View details →

Anthropic to embed permanent watermarks in EU AI content; Sea Limited beats Q2 revenue; 7Up refreshes flavor and branding.Seeking Alpha · 20 hours agoNeutral Sea Limited shares jump 13.8% after strong Q1 revenue growth and reinvestment strategy24/7 Wall Street · 20 hours agoBullish View details →

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

About Sea Limited

Sea Limited offers information technology services. The Company provides online personal computer and mobile digital content, e-commerce, and payment platforms. Sea serves customers worldwide.